By Yafo Life Sciences
January 12th, 2022 (Shanghai) — We are glad to announce that Tomas de Wouters, the CEO of PharmaBiome Ltd, has been invited to showcase at ACCESS CHINA Biotech Forum during Jan 4th – Jan14th. ACCESS CHINA Biotech Forum is the largest online corporate access event between China and the western biopharma industry.
If you are interested in listening to the live event, please register at https://biotochina.org/register/
About PharmaBiome Ltd
PharmaBiome is pioneering the development of next-generation microbiome-based therapies. Our research gave rise to a unique combination of ecological insights into the microbiome and a cutting edge production technology, with the potential to deliver live biotherapeutics for inflammatory diseases and oncology.
About ACCESS CHINA
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. View more information at https://biotochina.org/access-china-forum/
Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact: